
About this Post
This is an article from Psychedelic Science Review. Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible.
References
Krestel H, Bassetti CL, Walusinski O. Yawning—Its anatomy, chemistry, role, and pathological considerations. Progress in Neurobiology. 2018;161:61-78. doi:10.1016/j.pneurobio.2017.11.003
Argiolas A, Melis MR. The neuropharmacology of yawning. European Journal of Pharmacology. 1998;343(1):1-16. doi:10.1016/S0014-2999(97)01538-0
de Gorter J. De Perspiratione Insensibili Sanctoriana-Batava: Tractatus, Experimentis Propriis in Hollandia. Sumptibus Auctoris & Prostant apud Janssonios Vander, Lugduni Batavorum; 1725.
Daquin G, Micallef J, Blin O. Yawning. Sleep Medicine Reviews. 2001;5(4):299-312. doi:10.1053/smrv.2001.0175
Provine RR, Hamernik HB. Yawning: Effects of stimulus interest. Bulletin of the Psychonomic Society. 1986;24(6):437-438. doi:10.3758/BF03330574
Brown BJ, Kim S, Saunders H, et al. A Neural Basis for Contagious Yawning. Current Biology. 2017;27(17):2713-2717.e2. doi:10.1016/j.cub.2017.07.062
Urba-Holmgren R, Holmgren B, Rodriguez R, Gonzalez RM. Serotonergic modulation of Yawning. Pharmacology Biochemistry and Behavior. 1979;11(3):371-372. doi:10.1016/0091-3057(79)90153-9
Collins GT, Eguibar JR. Neurophamacology of Yawning. In: Walusinski O, ed. Frontiers of Neurology and Neuroscience. Vol 28. Basel: KARGER; 2010:90-106. doi:10.1159/000307085
Nichols DE. Structure–activity relationships of serotonin 5-HT2A agonists. Wiley Interdisciplinary Reviews: Membrane Transport and Signaling. 2012;1(5):559-579. doi:10.1002/wmts.42
Madsen MK, Fisher PM, Burmester D, et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology. January 2019:1. doi:10.1038/s41386-019-0324-9
Nichols DE. Psychedelics. Pharmacological Reviews. 2016;68(2):264-355. doi:10.1124/pr.115.011478